Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | DHFR | P00374 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.41 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1696798 | 0.94 | ALDH1A1 (0.52) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL27412107 | 0.94 | ALDH1A1 (0.49) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL2586996 | 0.92 | MAPT (0.52) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL31109976 | 0.91 | MEN1 (0.48) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL21195750 | 0.91 | MEN1 (0.48) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL2585614 | 0.89 | MEN1 (0.46) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL30507756 | 0.89 | MEN1 (0.46) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL762904 | 0.88 | ALDH1A1 (0.45) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL762897 | 0.88 | ALDH1A1 (0.43) | ALDH1A1NPSR1RAB9ALMNAGAA | |
| SCHEMBL29321146 | 0.88 | ALDH1A1 (0.45) | ALDH1A1NPSR1RAB9ALMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3639308-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2023-07-26 | — | — | EP | disclosed |
| EP-3809479-B1 | ORGANIC ELECTROLUMINESCENT DEVICE EMITTING BLUE LIGHT | SAMSUNG DISPLAY CO LTD (KR) | 2023-07-12 | — | — | EP | disclosed |
| US-11165035-B2 | Organic electroluminescent device emitting blue light | CYNORA GMBH (DE) | 2021-11-02 | — | — | US | disclosed |
| EP-3483156-B1 | ORGANIC MOLECUES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-09-16 | — | — | EP | disclosed |
| EP-3613744-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-02-26 | — | — | EP | disclosed |
| US-20190177303-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-13 | — | — | US | disclosed |
| EP-3483156-A1 | ORGANIC MOLECUES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-05-15 | — | — | EP | disclosed |
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| US-9062368-B2 | Method of monitoring photoactive organic molecules in-situ during gas-phase deposition of the photoactive organic molecules | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-06-23 | — | — | US | disclosed |
| US-8048542-B2 | Bis-phenanthroimidazolyl compound and electroluminescent device using the same | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-11-01 | — | — | US | disclosed |
| US-20100253208-A1 | BIS-PHENANTHROIMIDAZOLYL COMPOUND AND ELECTROLUMINESCENT DEVICE USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100253208-A1 | BIS-PHENANTHROIMIDAZOLYL COMPOUND AND ELECTROLUMINESCENT DEVICE USING THE SAME | SLC43A3, SLC29A1, SLC29A2 | ALDH1A1 927/4885NPSR1 1614/4885RAB9A 621/4885 |
| US-20190177303-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | ALDH1A1 542/4885NPSR1 1737/4885RAB9A 3768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.